Filtered By:
Vaccination: Pneomococcal Vaccine

This page shows you your search results in order of relevance. This is page number 12.

Order by Relevance | Date

Total 3041 results found since Jan 2013.

Community-acquired pneumonia among children: the latest evidence for an updated management.
CONCLUSIONS: Distinct aspects of childhood community-acquired pneumonia have changed during the last three decades. PMID: 31518547 [PubMed - as supplied by publisher]
Source: Jornal de Pediatria - September 9, 2019 Category: Pediatrics Authors: Nascimento-Carvalho CM Tags: J Pediatr (Rio J) Source Type: research

The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology
Conclusions: Our review highlights similarities and differences in the application of the test-negative design that deserve further examination. If vaccination reduces disease severity in breakthrough infections, particular care must be taken in interpreting vaccine effectiveness estimates from test-negative design studies.
Source: Epidemiology - December 3, 2019 Category: Epidemiology Tags: Methods Source Type: research

Cambridge ’ s Moderna Therapeutics Ramps Up Search For Coronavirus Vaccine
BOSTON (CBS) – The coronavirus has killed more than two dozen people in China and the race to create a vaccine is on at Cambridge-based biotech company Moderna Therapeutics. A team of scientists in their Norwood lab are working with the National Institutes of Health to research coronavirus. However, to distribute a vaccine around the world, Moderna President Dr. Steven Hoge said they need federal help. “There are going to be a continuing stream of public health threats, viruses that jump into humans from other species and the longer we wait to respond, the bigger that threat becomes,” Dr. Hoge told CBS News. “The f...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 24, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Business Health Syndicated CBSN Boston Syndicated Local Coronavirus Dr. Steven Hoge Moderna Therapeutics Source Type: news

Doctors in China Are Starting Human Trials for a Coronavirus Treatment
China has kick-started a clinical trial to speedily test a drug for the novel coronavirus infection as the nation rushes therapies for those afflicted and scours for vaccines to protect the rest. Remdesivir, a new antiviral drug by Gilead Sciences Inc. aimed at infectious diseases such Ebola and SARS, will be tested by a medical team from Beijing-based China-Japan Friendship Hospital for efficacy in treating the deadly new strain of coronavirus, a hospital spokeswoman told Bloomberg News Monday. Trial for the drug will be conducted in the central Chinese city of Wuhan — ground zero of the viral outbreak that has so f...
Source: TIME: Health - February 3, 2020 Category: Consumer Health News Authors: Bloomberg Tags: Uncategorized 2019-nCoV Bloomberg onetime overnight Source Type: news

Human genetics of life-threatening influenza pneumonitis
AbstractInfluenza viruses infect millions of people around the globe annually, usually causing self-limited upper respiratory tract infections. However, a small but non-negligible proportion of patients suffer from life-threatening pulmonary disease. Those affected include otherwise healthy individuals, and children with primary infections in particular. Much effort has been devoted to virological studies of influenza and vaccine development. By contrast, the enormous interindividual variability in susceptibility to influenza has received very little attention. One interesting hypothesis is that interindividual variability...
Source: Human Genetics - February 4, 2020 Category: Genetics & Stem Cells Source Type: research

Pharmacists' impact on older adults' access to vaccines in the United States.
CONCLUSION: Vaccinations are important in protecting and maintaining the health of older adults. Pharmacists improved access to vaccinations and served many roles in the vaccination process. Future research should explore how pharmacists impact access to vaccines beyond vaccination rates, especially regarding the financial impact on patients. PMID: 32046889 [PubMed - as supplied by publisher]
Source: Vaccine - February 7, 2020 Category: Allergy & Immunology Authors: Beal JL, Kadakia NN, Reed JB, Illingworth Plake KS Tags: Vaccine Source Type: research

New Strategy Is Needed to Prevent Pneumococcal Meningitis
Conclusions: Because virtually all cases of pneumococcal meningitis lead to either permanent neurologic sequelae or death, it would be well worth the effort to develop a new vaccine capable of preventing pneumococcal meningitis regardless of capsular type. Such a vaccine would need to protect against colonization with most, if not all, pneumococci.
Source: The Pediatric Infectious Disease Journal - March 14, 2020 Category: Infectious Diseases Tags: Commentary Source Type: research

Novel Target Exploration from Hypothetical Proteins of Klebsiella pneumoniae MGH 78578 Reveals a Protein Involved in Host-Pathogen Interaction
The opportunistic pathogen Klebsiella pneumoniae is a causative agent of several hospital-acquired infections. It has become resistant to a wide range of currently available antibiotics, leading to high mortality rates among patients; this has further led to a demand for novel therapeutic intervention to treat such infections. Using a series of in silico analyses, the present study aims to explore novel drug/vaccine candidates from the hypothetical proteins of K. pneumoniae. A total of 540 proteins were found to be hypothetical in this organism. Analysis of these 540 hypothetical proteins revealed 30 pathogen-specific prot...
Source: Frontiers in cellular and infection microbiology - April 2, 2020 Category: Microbiology Source Type: research

Coronavirus disease 2019: a bibliometric analysis and review.
CONCLUSIONS: According to our review, China has provided a large number of research data for various research fields, during the outbreak of COVID-19. Most of the findings play an important role in preventing and controlling the epidemic around the world. With research on the COVID-19 still booming, new vaccine and effective medicine for COVID-19 will be expected to come out in the near future with the joint efforts of researchers worldwide. PMID: 32271460 [PubMed - as supplied by publisher]
Source: European Review for Medical and Pharmacological Sciences - April 10, 2020 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research

IJERPH, Vol. 17, Pages 2655: Benefits of Exercise on Influenza or Pneumonia in Older Adults: A Systematic Review
Yaodong Gu A coronavirus pandemic has recently become one of the greatest threats the world is facing. Older adults are under a high risk of infection because of weaker immune systems. Therefore, the purpose of this review is to summarize the recent scientific evidence that outlines the effects of exercise on influenza or pneumonia in older adults. An electronic literature search was conducted using the WEB OF SCIENCE, SCIENCEDIRECT and GOOGLE SCHOLAR databases using the following keywords, “Exercise,” “Older adult,” “Influenza,” and “Pneumonia.” Any randomized control trials, cross-sectional and obse...
Source: International Journal of Environmental Research and Public Health - April 12, 2020 Category: Environmental Health Authors: Yang Song Feng Ren Dong Sun Meizi Wang Julien S. Baker B író István Yaodong Gu Tags: Review Source Type: research

Vaccines, Antibodies and Drug Libraries. The Possible COVID-19 Treatments Researchers Are Excited About
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

All Your Coronavirus Questions, Answered
One of the worst symptoms of any plague is uncertainty—who it will strike, when it will end, why it began. Merely understanding a pandemic does not stop it, but an informed public can help curb its impact and slow its spread. It can also provide a certain ease of mind in a decidedly uneasy time. Here are some of the most frequently asked questions about the COVID-19 pandemic from TIME’s readers, along with the best and most current answers science can provide. A note about our sourcing: While there are many, many studies underway investigating COVID-19 and SARS-CoV-19, the novel coronavirus that causes the illn...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized COVID-19 Explainer Source Type: news

Risk Factors for Carriage of Antibiotic-resistant Bacteria in Healthy Children in the Community: A Systematic Review
Conclusions: The factors that promote carriage of AR bacteria by healthy children differed between bacterial species. To reduce reservoirs of AR bacteria in the community, it is essential for intervention strategies to target the specific risk factors for different bacteria.
Source: The Pediatric Infectious Disease Journal - April 16, 2020 Category: Infectious Diseases Tags: Antimicrobial Reports Source Type: research

A systematic review and meta-analysis of serotype distribution of Streptococcus pneumoniae in Iran: Practical evidences to optimizing local vaccination protocols.
CONCLUSION: In the present study, it was found that over the last decade, the most prevalent serotypes in Iran were 19, 23, 6, and 14, respectively. These findings provides practical evidences to select effective pneumococcal vaccine candidates in the prevention of invasive diseases in Iranian patients, and also comparing our situation with others. PMID: 32310053 [PubMed - as supplied by publisher]
Source: Infectious Disorders Drug Targets - April 18, 2020 Category: Infectious Diseases Authors: Karimi A, Hoseini-Alfatemi SM, Tabatabaei SR Tags: Infect Disord Drug Targets Source Type: research

COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
Conclusions: First-level treatments include repurposing antivirals and antimalarials, and plasma infusion should help, but development of existing or new molecules into vaccines will take time. The unpredictable trajectory of this outbreak demands careful surveillance to monitor the situation, draw strategies, implement control measures, and create proper ethical laws and medical guidelines. PMID: 32412918 [PubMed - as supplied by publisher]
Source: Alternative Therapies in Health and Medicine - May 14, 2020 Category: Complementary Medicine Authors: Khan T, Agnihotri K, Tripathi A, Mukherjee S, Agnihotri N, Gupta G Tags: Altern Ther Health Med Source Type: research